SLC29A1 and gestational diabetes: It is also known that NO inhibits SLC29A1 (for hENT1) promoter transcriptional activity in HUVEC from GDM, where a higher NO synthesis due to eNOS activation (phosphorylation of eNOS at Ser1177 residue) [39] as well as increased total eNOS expression [59] is reported.